Schedule 13G ownership disclosure
KINIKSA PHARMACEUTICALS LTD
Security class unavailable · CUSIP: G5269C101
Event date: 2019-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 0.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193805-20-000197
- Form type
- SC 13G
- Filer
- Flynn James E
- CIK
- CIK 1352546
- Filed
- Feb 13, 2020
- Reporting period
- Dec 31, 2019
- Description
- Schedule 13G beneficial ownership